A major role for mitotic cdc2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint

Cancer Research

Volumn 64, Issue 24, 2004, Pages 8954-8959

  Bayart, Emilie ^a,b   Grigorieva, Olga ^a,b   Leibovitch, Serge ^a,c   Onclercq Delic, Rosine ^a,b   Amor Guéret, Mounira ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEMECOLCINE; PROTEIN KINASE; ROSCOVITINE;

ARTICLE; BLOOM SYNDROME; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MITOSIS; MITOSIS SPINDLE; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATASES; CDC2 PROTEIN KINASE; CELL DIVISION; CHLOROQUINE; DNA; DNA DAMAGE; DNA HELICASES; ENZYME ACTIVATION; G1 PHASE; HELA CELLS; HUMANS; HYDROXAMIC ACIDS; MITOSIS; PHOSPHORYLATION; PURINES; SUBCELLULAR FRACTIONS;

EID: 10844237360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1613     Document Type: Article

References (26)

1. Hickson ID. RecQ helicases: caretakers of the genome. Nat Rev Cancer 2003;3:169-78.
2. Dutertre S, Ababou M, Onclercq R, et al. Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase. Oncogene 2000;19:2731-8.
3. Dutertre S, Sekhri R, Tintignac LA, et al. Dephosphorylation and subcellular compartment change of the mitotic Bloom's syndrome DNA helicase in response to ionizing radiation. J Biol Chem 2002;277:6280-6.
4. Kung AL, Sherwood SW, Schimke RT. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc Natl Acad Sci USA 1990;87:9553-7.
5. Burke DJ. Complexity in the spindle checkpoint. Curr Opin Genet Dev 2000;10:26-31.
6. Poon RY, Chau MS, Yamashita K, Hunter T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res 1997;57:5168-78.
7. Chow JP, Siu WY, Fung TK, et al. DNA damage during the spindle-assembly checkpoint degrades CDC25 A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase. Mol Biol Cell 2003;14:3989-4002.
8. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506.
9. Yoshida M, Horinouchi S, Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 1995;17:423-30.
10. Krajewski WA. Alterations in the internucleosomal DNA helical twist in chromatin of human erythroleukemia cells in vivo influences the chromatin higher-order folding. FEBS Lett 1995;361:149-52.
11. Martinez-Balbas MA, Dey A, Rabindran SK, et al. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 1995;83:29-38.
12. Muchardt C, Reyes JC, Bourachot B, Leguoy E, Yaniv M. The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J 1996;15:3394-402.
13. Frei C, Gasser SM. The yeast Sgs1p helicase acts upstream of Rad53p in the DNA replication checkpoint and colocalizes with Rad53p in S-phase-specific foci. Genes Dev 2000;14:81-96,
14. Meijer L, Borgne A, Mulner O, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997;243:527-36.
15. Earnshaw WC, Halligan B, Cooke CA, Heck MM, Liu LF. Localization of topoisomerase 11 in mitotic chromosomes. J Cell Biol 1985;100:1706-15.
16. Pines J, Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 1989;58:833-46.
17. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001;276:42462-7.
18. De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 1997;243:518-26.
19. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2000;2:672-6.
20. Margolis RL, Lohez OD, Andreassen PR. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 2003;88:673-83.
21. Ababou M, Dumaire V, Lecluse Y, Amor-Gueret M. Cleavage of BLM and sensitivity of Bloom's syndrome cells to hydroxurea and UV-C radiation. Cell Cycle 2002;1:262-6.
22. Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 2002;9:1287-93.
23. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994;79:547-50.
24. Itzhaki JE, Gilbert CS, Porter AC. Construction by gene targeting in human cells of a "conditional" CDC2 mutant that rereplicates its DNA. Nat Genet 1997;15:258-65.
25. Wuarin J, Buck V, Nurse P, Millar JB. Stable association of mitotic cyclin B/Cdc2 to replication origins prevents endoreduplication. Cell 2002;111:419-31.
26. O'Connor DS, Wall NR, Porter AC, Altieri DC. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2002;2:43-54.